PALISADE BIO, INC. — Director's Dealing 2014

Jan 27, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2014-01-24

Reporting Person: GARR RICHARD (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-24	Common Stock	M	400000	$0.50	Acquired	1455327	Direct
2014-01-24	Common Stock	F	65789	$3.04	Disposed	1389538	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-24	Common Stock Purchase Option	$0.50	M	400000	Disposed	2015-07-28	Common Stock (400000)	Direct

Footnotes

F1: Represents shares issued/cancelled upon the cashless exercise of an option to purchase 400,000 shares of Common Stock at an exercise price of $0.50 per share using a fair market value of the Issuer's stock on 1/24/12 of $3.04.

F2: Represents the cashless exercise of an option to purchase shares of Common Stock at an exercise price of $0.50.

F3: Right to Buy.